Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity
Publication
, Conference
Loeb, E; Fergione, S; Yudistyra, V; Fanous, M; Benkert, A; Retana, MAV; Fisher, D; Asokan, A
Published in: MOLECULAR THERAPY
2025
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Loeb, E., Fergione, S., Yudistyra, V., Fanous, M., Benkert, A., Retana, M. A. V., … Asokan, A. (2025). Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity. In MOLECULAR THERAPY (Vol. 33).
Loeb, Ezra, Sophia Fergione, Vivian Yudistyra, Marco Fanous, Abigail Benkert, Ma Alejandra Vargas Retana, Delaney Fisher, and Aravind Asokan. “Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity.” In MOLECULAR THERAPY, Vol. 33, 2025.
Loeb E, Fergione S, Yudistyra V, Fanous M, Benkert A, Retana MAV, et al. Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity. In: MOLECULAR THERAPY. 2025.
Loeb, Ezra, et al. “Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity.” MOLECULAR THERAPY, vol. 33, no. 4, 2025.
Loeb E, Fergione S, Yudistyra V, Fanous M, Benkert A, Retana MAV, Fisher D, Asokan A. Engineering non-mammalian chimeric AAVs for evasion of pre-existing antibodies and vector-induced immunity. MOLECULAR THERAPY. 2025.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
2025
Volume
33
Issue
4
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences